help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, C. W. Y.
Right arrow Articles by Silverman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C. W. Y.
Right arrow Articles by Silverman, M.
Endocrinology Vol. 138, No. 11 4732-4739
Copyright © 1997 by The Endocrine Society


ARTICLES

Studies of Melatonin Effects on Epithelia Using the Human Embryonic Kidney-293 (HEK-293) Cell Line1

C. W. Y. Chan, Y. Song2, M. Ailenberg, M. Wheeler, S. F. Pang, G. M. Brown3 and M. Silverman4

The Clarke Institute of Psychiatry (C.W.Y.C., G.M.B.), Toronto, Ontario, M5T 1R8, Canada; Medical Research Council Membrane Biology Group (Y.S., M.S.), Department of Medicine, University of Toronto, Medical Science Building, Toronto, Ontario, M5S 1A8, Canada; Department of Medicine (M.W.), University of Toronto, Toronto, Ontario, M5S 1A8, Canada; and Department of Physiology (S.F.P.), University of Hong Kong, Hong Kong

Address all correspondence and requests for reprint to: Dr. M. Silverman, Medical Research Council Membrane Biology Group, Department of Medicine, University of Toronto, Medical Science Building, Toronto, Ontario M5S 1A8, Canada.

The expression of melatonin receptors (MR) of the Mel1a subtype in basolateral membrane of guinea pig kidney proximal tubule suggests that melatonin plays a role in regulating epithelial functions. To investigate the cellular basis of melatonin action on epithelia, we sought to establish an appropriate in vitro culture model. Epithelial cell lines originating from kidneys of dog (MDCK), pig (LLC-PK1), opossum (OK), and human embryo (HEK-293) were each tested for the presence of MR using 2-[125I]iodomelatonin (125I-MEL) as a radioligand. The HEK-293 cell line exhibited the highest specific 125I-MEL binding. By intermediate filament characterization, the HEK-293 cells were determined to be of epithelial origin. Binding of 125I-MEL in HEK-293 cells demonstrated saturability, reversibility, and high specificity with an equilibrium dissociation constant (Kd) value of 23.8 ± 0.5 pM and a maximum number of binding sites (Bmax) value of 1.17 ± 0.11 fmol/mg protein (n = 5), which are comparable with the reported Kd and Bmax values in human kidney cortex. Coincubation with GTP{gamma}S (10 µM) and pertussis toxin (100 ng/ml) provoked a marked decrease in binding affinity (Kd was increased by a factor of 1.5–2.0), with no significant difference in Bmax. Melatonin (1 µM) decreased the forskolin (10 µM) stimulated cAMP level by 50%. HEK-293 cells do not express dopamine D1A receptor. Following transient transfection of HEK-293 cells with human dopamine D1A receptor (hD1A-R), exposure of the cells to dopamine stimulated an increase in the level of cAMP. Similarly, transient transfection of HEK-293 cells with rat glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and PTH type 1 receptors, each resulted in an hormone inducible increase in cAMP levels. Surprisingly, only the stimulatory effect of dopamine could be inhibited by exposure to melatonin. The inhibitory effect of melatonin on dopamine D1-induced increase in cAMP was completely inhibited by pertussis toxin (100 ng/ml, 18 h). Immunoblot and immunocytochemical studies were carried out using two polyclonal antibodies raised against the extra and cytoplasmic domains of Mel1a receptor. Immunoblot studies using antibody against the cytoplasmic domain of Mel1a receptor confirmed the presence of a peptide blockable 37 kDa band in HEK-293 cells. Indirect immunofluorescent studies with both antibodies revealed staining predominantly at the cell surface, but staining with the antibody directed against the cytoplasmic domain required prior cell permeabilization. By RT-PCR, HEK-293 cells express both Mel1a and Mel1b messenger RNAs, but the messenger RNA level for Mel1b is several orders of magnitude lower than for Mel1a.

We conclude that HEK-293 cells express MR predominantly of the Mel1a subtype. Our evidence suggests that one of the ways that melatonin exerts its biological function is through modulation of cellular dopaminergic responses.




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. G. Richter, C. Torres-Farfan, J. Garcia-Sesnich, L. Abarzua-Catalan, M. G. Henriquez, M. Alvarez-Felmer, F. Gaete, G. E. Rehren, and M. Seron-Ferre
Rhythmic Expression of Functional MT1 Melatonin Receptors in the Rat Adrenal Gland
Endocrinology, March 1, 2008; 149(3): 995 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
Mohd. A. Rahman, Y. Azuma, H. Fukunaga, T. Murakami, K. Sugi, H. Fukushi, K. Miura, H. Suzuki, and M. Shirai
Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia
J. Antimicrob. Chemother., November 1, 2005; 56(5): 861 - 868.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Scher, E. Wankiewicz, G. M. Brown, and H. Fujieda
MT1 Melatonin Receptor in the Human Retina: Expression and Localization
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 889 - 897.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Cui, J. König, U. Buchholz, H. Spring, I. Leier, and D. Keppler
Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells
Mol. Pharmacol., May 1, 1999; 55(5): 929 - 937.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society